SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-042436
Filing Date
2023-08-14
Accepted
2023-08-14 16:19:37
Documents
68
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q acer-20230630.htm   iXBRL 10-Q 3485547
2 EX-10.2 acer-ex10_2.htm EX-10.2 147992
3 EX-31.1 acer-ex31_1.htm EX-31.1 20614
4 EX-31.2 acer-ex31_2.htm EX-31.2 20827
5 EX-32.1 acer-ex32_1.htm EX-32.1 13156
6 EX-32.2 acer-ex32_2.htm EX-32.2 12916
7 GRAPHIC img229397536_0.jpg GRAPHIC 17508
  Complete submission text file 0000950170-23-042436.txt   14604053

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acer-20230630.xsd EX-101.SCH 93235
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acer-20230630_pre.xml EX-101.PRE 519887
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acer-20230630_cal.xml EX-101.CAL 48643
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acer-20230630_lab.xml EX-101.LAB 680671
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acer-20230630_def.xml EX-101.DEF 376175
62 EXTRACTED XBRL INSTANCE DOCUMENT acer-20230630_htm.xml XML 3008118
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33004 | Film No.: 231170572
SIC: 2834 Pharmaceutical Preparations